TEST CATALOG ORDERING & RESULTS SPECIMEN HANDLING CUSTOMER SERVICE EDUCATION & INSIGHTS
Test Catalog
Print Page

Test ID: P2PHI    
[-2]Pro Prostate Specific Antigen with Prostate Health Index, Serum

 Download Test

Useful For Suggests clinical disorders or settings where the test may be helpful

Aids in distinguishing prostate cancer from benign prostate conditions in men 50 years of age and older with prostate-specific antigen (PSA) results in the 4 to 10 ng/mL range and digital rectal examination (DRE) findings that are not suspicious for cancer

Highlights

Prostate health index (phi) may be used to determine the probability of prostate cancer on biopsy in men with prostate-specific antigen (PSA) in the 4.0 to 10.0 ng/mL range.

 

This test will generate results for PSA, free PSA and [-2]ProPSA regardless of PSA concentration.

 

Percent free PSA and phi calculations will only be reported when the initial PSA value is between 4.0 and 10.0 ng/mL.

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

This test begins with the analysis of prostate specific antigen (PSA), free PSA, and [-2]proPSA. If the initial PSA is between 4.0 and 10.0 ng/mL, then the percent free PSA and the prostate health index (phi) will be calculated and reported.

Method Name A short description of the method used to perform the test

Immunoenzymatic Assay

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

p2PSA with Prostate Health Index, S

Aliases Lists additional common names for a test, as an aid in searching

P2PSA
PHI
Pro-2-PSA
Prostate Health Index